Feature | Cardiovascular Business | January 29, 2024

Trending Charts: A Look at DAIC's Highest Viewed Comparison Charts in 2023

DAIC's exclusive, specialized cardiology product comparison charts help with your purchasing decisions

DAIC's exclusive, specialized cardiology product comparison charts help with your purchasing decisions

Did you know that Diagnostic and Interventional Cardiology (DAIC) maintains more than 40 comparison charts of product specifications from various vendors, offering a side-by-side, apples-to-apples comparison when making purchasing decisions? These charts can save hours of research, and offer links back to the websites of each vendor for additional information. The charts were created by DAIC by sending out a questionnaire to each of the vendors listed. 

Our one-of-a-kind comparison charts allow you to do a side-by-side review of the latest technologies and products from the industry’s leading vendors. All of the charts can be accessed here, or using the links below. Access requires a login but it is free and only takes a minute to complete.

Here are links to the Top 10 viewed DAIC comparison charts from 2023:

1. Guidewires

2. Angiography Systems

3. Hemodynamic Monitoring Systems

4. Cardiac CT Systems

5. Drug-Coated Balloons

6. Cardiovascular Ultrasound

7. Echocardiology Reporting Systems

8. PET/CT Systems

9. Cardiovascular Information Systems (CVIS)

10. ECG Systems


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now